Stocktoria
Tenon Medical, Inc. TNON
Nasdaq · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2022-04-27
Tenon Medical, Inc. financials (annual)
Bars are annual figures from 2021 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $3.9M | $3.3M | $2.9M | $691,000 | $160,000 |
| Gross profit | $2.4M | $1.7M | $1.2M | -$641,000 | $105,000 |
| R&D expense | $2.1M | $2.6M | $3.2M | $2.8M | $1.7M |
| Operating income | -$12.8M | -$13.8M | -$15.7M | -$18.7M | -$6.5M |
| Interest expense | — | — | $21,000 | $354,000 | — |
| Net income | -$12.6M | -$13.7M | -$15.6M | -$18.9M | -$7.0M |
| EPS (diluted) | $-1.70 | $-11.26 | $-68.64 | $-23.62 | $-7.81 |
| Operating cash flow | -$10.7M | -$9.9M | -$12.2M | -$12.0M | -$4.3M |
| Free cash flow | -$11.0M | -$10.1M | -$12.5M | -$12.9M | -$4.4M |
| Cash & equivalents | $3.8M | $6.5M | $2.4M | $2.1M | $2.9M |
| Inventory | $1.1M | $606,000 | $554,000 | $415,000 | $188,000 |
| Total assets | $10.8M | $9.8M | $6.3M | $11.1M | $9.3M |
| Total liabilities | $5.7M | $3.9M | $5.6M | $4.8M | $16.2M |
| Shareholders' equity | $5.0M | $6.0M | $778,000 | $6.3M | -$20.6M |
Growth · year-over-year · Revenue CAGR 122.8%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue growth | +20.4% | +11.9% | +323.7% | +331.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.